21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer

Kizy Scott; Altman Ariella M.; Marmor Schelomo; Denbo Jason W.; Jensen Eric H.; Tuttle Todd M.; Hui Jane Yuet Ching

首页> 外文期刊>Journal of geriatric oncology >21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer

【24h】

21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer

机译：雌激素受体阳性乳腺癌的较老群中的21-基因复发评分测试

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Introduction: The 21-gene recurrence score (RS) (Oncotype Dx, Genomic Health, Redwood City Ca) has not been validated in an older cohort with estrogen receptor (ER)-positive breast cancer. The objective of this study was to evaluate RS validity in a group of older women with ER-positive breast cancer.

机译：介绍：21-基因复发评分（RS）（ONCotype DX，Genomic Health，Redwood City CA）尚未在较旧的队列中验证雌激素受体（ER）阳性乳腺癌。本研究的目的是评估一组患有ER阳性乳腺癌的老年女性的RS有效性。

著录项

来源
《Journal of geriatric oncology》 |2019年第2期|共8页
作者
Kizy Scott; Altman Ariella M.; Marmor Schelomo; Denbo Jason W.; Jensen Eric H.; Tuttle Todd M.; Hui Jane Yuet Ching;
展开▼
作者单位

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

Univ Minnesota Dept Surg Minneapolis MN 55455 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Breast Cancer; Geriatric; Recurrence Score; Genomic Testing;

机译：乳腺癌;老年人;复发得分;基因组测试;

相似文献

外文文献
中文文献
专利

1. 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer [J] . Kizy Scott, Altman Ariella M., Marmor Schelomo, Journal of geriatric oncology . 2019,第2期

机译：雌激素受体阳性乳腺癌的较老群中的21-基因复发评分测试
2. Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer [J] . Koh Minji, Jung Jinhong, Kim Su Ssan, Breast cancer research and treatment. . 2021,第3期

机译：雌激素受体阳性乳腺癌患者区域复发评分的预后价值
3. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer [J] . Turashvili Gulisa, Chou Joanne F., Brogi Edi, Breast cancer research and treatment. . 2017,第1期

机译：淋巴结阴性，雌激素受体阳性乳腺癌的21-基因复发评分和型患者
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. The SERM, arzoxifene, and the rexinoid, LG100268, cooperate to prevent estrogen receptor-positive and -negative breast cancer as well as colon cancer. [D] . Rendi, Mara H. 2004

机译：SERM，arzoxifene和类维生素LG100268共同预防雌激素受体阳性和阴性乳腺癌以及结肠癌。
6. 21-Gene recurrence score and locoregional recurrence in lymph node-negative estrogen receptor-positive breast cancer [O] . Gulisa Turashvili, Joanne F. Chou, Edi Brogi, -1

机译：淋巴结阴性雌激素受体阳性乳腺癌的21基因复发评分和局部复发
7. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer [O] . Gulisa Turashvili, Joanne F. Chou, Edi Brogi, 2017

机译：淋巴结阴性，雌激素受体阳性乳腺癌的21-基因复发评分和型患者

21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅